All Posts By

admin

IBTA e-News – November 2013

By e-News Archive

Dear Friend,

Society for Neuro Oncology (SNO) Conference: The Annual Scientific meeting of SNO will be held in San Francisco during 21-24 November, with the Education Day taking place on 21 November. It will be held in conjunction with the Quadrennial Conference of the World Federation of Neuro Oncology (WFNO), which was last held in Yokohama, Japan, in 2009. The preliminary program is available here. The IBTA will have a display table at the meeting and we invite our contacts and others to visit us and introduce themselves…

Read More

IBTA e-News – October 2013

By e-News Archive

European Cancer Congress (ECC): There appeared to be no highly significant new results in the area of CNS tumours presented at the ECC held in Amsterdam, except for reinforcement of the relevance of IDH mutations. Contributions mainly dealt with the finalisation of previously indicated trial results. This is a link to the CNS abstracts…

Read More

IBTA e-News – September 2013

By e-News Archive

Neurosurgeons resign after Inquiry: In a case that has attracted widespread interest because of the issues it raises about the treatment of glioblastoma patients two UC Davis (USA) neurosurgeons have resigned after several inquiries criticised their action in unsuccessfully introducing live bowel bacteria directly into their patients’ brains or bone flaps in the hope that an infection might stimulate the patients’ immune systems…

Read More

IBTA e-News – August 2013

By e-News Archive

Existing drugs might help glioblastoma patients: Researchers have identified 18 new genes responsible for driving GBM brain tumours. The researchers believe that for about 15 per cent of patients whose tumours are driven by certain gene fusions, FDA-approved drugs that target those drivers are already available. They caution, however, that a complicated analysis is necessary to identify a tumour’s driver gene before a personalised glioblastoma treatment can become a reality…

Read More

IBTA e-News – July 2013

By e-News Archive

Hormone replacement therapy (HRT) and meningiomas: A Danish study of 924 women who had a meningioma has led to a claim that women on HRT have a 30 percent greater risk of getting a meningioma brain tumour but the findings have been dismissed by experts in women’s health. One consultant endocrinologist said that the risk might only represent one per 100,000 women per year and was “an absolutely trivial risk and of no clinical or biological importance”. Another expert said that with women who experience early menopause the benefits of HRT are likely to substantially outweigh the long-term risks without HRT, which included osteoporosis and cardiovascular diseases…

Read More

IBTA e-News – June 2013

By e-News Archive

ASCO and Avastin (bevacizumab): The results of two important clinical trials involving Avastin and glioblastoma were presented at the annual meeting of the American Society of Clinical Oncology (ASCO) held in Chicago during 31 May – 4 June 2013. The two trials were RTOG 0825 (a double-blind placebo-controlled trial of Avastin in patients with newly-diagnosed GBM) and AVAglio (progression-free survival and health-related quality of life involving Avastin, temozolomide and radiotherapy in newly-diagnosed GBM)…

Read More

let us know you agree to cookies

The IBTA website uses cookies to give you the best online experience in accordance with our cookies policy. If you are happy, please confirm by clicking the 'Accept' button below.